Clinical Trial Update: Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

View source ↗

Summary

This completed observational study evaluated the efficacy and safety of NovoRapid Flexpen (insulin aspart) in people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoRapid Flexpen (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED